National News Coverage for MediSieve

National News Coverage for MediSieve
Created on 13-11-2019

Founder and CEO, Dr George Frodsham, speaks to the Telegraph on the birth and journey of MediSieve.

You may have seen us featured in the Telegraph on Sunday 10 November.

Here, Dr Frodsham, divulges how he came up with the idea while studying how magnetic nanoparticles can be made to bind to cells in the body, to allow, for example those cells to show up on scanners.

Read the full article here.

We were also fortunate enough to have this article featured in The Mirror.

Sort by:

Latest News

MediSieve expands its research into treating COVID-19
April 29, 2020

Recent studies show that patients with the most serious forms of the coronavirus had high levels of something called IL-6, a common inflammatory cytokine, which MediSieve has previously encountered while researching sepsis and cytokine storms.

COVID-19 Response
April 03, 2020

Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine storm syndromes, and that these are a major driver of mortality.